Ozempic healthcare provider Psychiatry > General Psychiatry Ozempic healthcare provider — Reports of suicidal ideation higher when compared to other drugs in WHO database by Kristen Monaco, Senior Staff Writer, MedPage Today August 20, 2024 A disproportionality analysis based on reports in a World Health Organization (WHO) database suggested a suicidal ideation signal with the […]
Ozempic clinical trials This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation. Looking at the data from clinical trials of new GLP-1 agonists, it’s clear that patients will need to stay on the drugs to maintain their weight […]
Ozempic doctor recommendation by Aude Bandini, Jean-Philippe Drouin-Chartier, Pierre-Marie David and Rémi Rabasa-Lhoret, The Conversation Credit: Pixabay/CC0 Public Domain The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the […]
Ozempic dosage On May 13, Sen. Bernie Sanders (I-Vt.) published an open letter to Novo Nordisk on the front page of a leading Danish newspaper, urging the hometown company to live up to its altruistic standards by lowering U.S. prices for its blockbuster diabetes and weight loss drugs. What Sanders didn’t realize was that Denmark, […]
Ozempic metabolism Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug. One study found U.S. prescriptions and refills of Ozempic (semaglutide) soaring over the past three years, jumping almost five-fold (392%) between early 2021 and the end of […]
Ozempic prescription Pulmonology > Smoking & Tobacco Ozempic prescription — Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics by Elizabeth Short, Staff Writer, MedPage Today, July 30, 2024 Among patients with type 2 diabetes and tobacco use disorder (TUD), use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) […]
Ozempic renal function Endocrinology > General Endocrinology Ozempic renal function — News and commentary from the endocrinology world by Kristen Monaco, Senior Staff Writer, MedPage Today July 16, 2024 Only 25% of patients prescribed semaglutide (Ozempic, Wegovy) for weight loss were still on it 2 years later, according to an analysis of U.S. pharmacy claims […]
Ozempic gastrointestinal effects Credit: Pietro Jeng from Pexels A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday. Published in the journal JAMA, the study compared patients with Type 2 diabetes who were treated with insulin versus patients […]
Ozempic doctor recommendation European drug authorities have issued recommendations to address ongoing shortages in glucagon-like peptide 1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity. These drugs include Ozempic (semaglutide), Saxenda (liraglutide), Trulicity (dulaglutide), and Victoza (liraglutide). Since 2022, GLP-1 receptor agonists have gained popularity on social media, where high profile influencers […]
Ozempic weight loss reviews ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73% in people with established cardiovascular disease and obesity compared with placebo, regardless of baseline A1c levels, according to two new analyses of the SELECT trial. […]
Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)
Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊